Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
AKCEA THERAPEUTICS, INC. (AKCA)
Sector: Healthcare; Industry: Biotechnology

Akcea Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines to treat patients with serious and rare diseases in the United States and internationally. The company also develops AKCEA-APO(a)-LRx, which has completed Phase IIb clinical study for treating hyperlipoproteinemia; AKCEA-ANGPTL3-LRx that has completed Phase IIb clinical study for the treatment of homozygous familial hypercholesterolemia; and AKCEA-APOCIII-LRx, which is in Phase II study for the treatment of cardiovascular disease due to elevated triglyceride levels, as well as AKCEA-TTR-LRx to treat the broad population of patients with hereditary and wild-type forms of transthyretin amyloidosis. The company was incorporated in 2014 and is headquartered in Boston, Massachusetts. Akcea Therapeutics, Inc. is a subsidiary of Ionis Pharmaceuticals, Inc.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-10-10 IONIS PHARMACEUTICALS INC 10%-Owner Buy 21,237,715 $18.15 $385,464,527 No
2020-09-22 Patterson Joshua F. General Counsel Sell 319 $18.12 $5,780 No
2020-09-22 Jenne Kyle Chief Commercial Officer Sell 720 $18.12 $13,046 No
2020-09-22 McDevitt Damien Chief Executive Officer Sell 8,709 $18.12 $157,807 No
2020-07-17 Patterson Joshua F. General Counsel Sell 263 $12.50 $3,288 No
2020-03-23 Patterson Joshua F. General Counsel Sell 335 $11.76 $3,938 No
2020-03-23 Jenne Kyle Chief Commercial Officer Sell 779 $11.75 $9,153 No
2020-03-23 O'Dea Louis Chief Medical Officer Sell 3,198 $11.75 $37,579 No
2020-03-23 McDevitt Damien Chief Executive Officer Sell 9,417 $11.75 $110,649 No
2019-07-15 Boyce Sarah President Sell 1,819 $23.52 $42,783 No
2019-04-08 Goldberg Jeff Marc Chief Operating Officer Sell 50,000 $31.71 $1,585,718 Yes
2019-04-08 Soteropoulos Paula Chief Executive Officer Sell 31,787 $32.11 $1,020,780 Yes
2019-03-06 Soteropoulos Paula Chief Executive Officer Sell 18,386 $32.14 $590,856 Yes
2018-04-17 IONIS PHARMACEUTICALS INC 10%-Owner Buy 10,666,666 $18.75 $199,999,988 No
2017-07-19 IONIS PHARMACEUTICALS INC 10%-Owner Buy 3,125,000 $8.00 $25,000,000 Yes

Insider Smart

Axsome Therapeutics, Inc (AXSM) - AXSM shows the power of an #allgreen stock, no insider selling, great management great company, if you follow the insiders last year and pick up around $25, the 52 week high is $100+.

Insider Smart

CARNIVAL CORP (CCL) - Cruislines $CCL $NCLH $RCL took a huge beat due to the pandemic, concerns of bankruptcy were raised. Among the three dominating companies in the industry, $CCL is the first one bought by insiders, such a bold move would definitely boost investor confidence.